title: Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney.
abstract: Calcineurin is a serine/threonine phosphatase originally involved in the immune response but is also known for its role as a central mediator in various non-immunological intracellular signals. The nuclear factor of activated T cell (NFAT) proteins are the most widely described substrates of calcineurin, but ongoing work has uncovered other substrates among which are the cytoskeleton organizing proteins (i.e. cofilin, synaptopodin, WAVE-1). Control over cytoskeletal proteins is of outmost interest because the phenotypic properties of cells are dependent on cytoskeleton architecture integrity, while rearrangements of the cytoskeleton are implicated in both physiological and pathological processes. Previous works investigating the role of calcineurin on the cytoskeleton have focused on neurite elongation, myocyte hypertrophic response and recently in kidney cells structure. Nuclear factor of activated T cell activation is expectedly identified in the signalling pathways for calcineurin-induced cytoskeleton organization, however new NFAT-independent pathways have also been uncovered. The aim of this review is to summarize the current knowledge on the effects of calcineurin on cytoskeletal proteins and related intracellular pathways. These newly described properties of calcineurin on cytoskeletal proteins may explain some of the beneficial or deleterious effects observed in kidney cells associated with the use of the calcineurin inhibitors, cyclosporine and tacrolimus.
authors.affiliation: Inserm, UMR-S850, Limoges, France.
authors.forename: Virginie
authors.initials: V
authors.lastname: Descazeaud
authors.forename: Elodie
authors.initials: E
authors.lastname: Mestre
authors.forename: Pierre
authors.initials: P
authors.lastname: Marquet
authors.forename: Marie
authors.initials: M
authors.lastname: Essig
mesh_terms: D019703:Calcineurin / Q000378:metabolism*; D065095:Calcineurin Inhibitors; D006332:Cardiomegaly / Q000473:pathology; D003599:Cytoskeleton / Q000502:physiology*; D006321:Heart / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000473:pathology; D050778:NFATC Transcription Factors / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
chemical_list: D065095:Calcineurin Inhibitors; D050778:NFATC Transcription Factors; D019703:Calcineurin